Summary: Apnimed Inc, a clinical-stage pharmaceutical company developing oral therapies for obstructive sleep apnea and other sleep disorders, will showcase findings from a recent clinical trial on obesity hypoventilation syndrome (OHS) at the European Respiratory Society (ERS) Congress in Vienna. The poster presentation will explore the prevalence and characteristics of patients with OHS, highlighting an area of unmet clinical need. Elisa Perger, MD, from the University of Milano Bicocca will present the data on Sept 8.
Key Takeaways:
- Focus on Obesity Hypoventilation Syndrome: Apnimed’s poster presentation at ERS 2024 will highlight the prevalence and physiological characteristics of patients with OHS, a condition linked to sleep-disordered breathing and obesity.
- Clinical Trial Data: The findings are derived from a recent clinical trial sponsored by Apnimed.
- Upcoming ERS Congress: The presentation will take place at the European Respiratory Society Congress in Vienna on Sept 8, with Elisa Perger, MD, leading the discussion on early detection of OHS in obese patients.
Apnimed Inc, a clinical-stage pharmaceutical company focused on developing novel oral therapies for the treatment of obstructive sleep apnea (OSA) and other sleep disorders, announced the company will be showcasing a poster presentation at the upcoming European Respiratory Society Congress taking place Sept 7-11 in Vienna, Austria.
The poster will present findings on the prevalence and characteristics of patients presenting with obesity hypoventilation syndrome (OHS) based on data derived from a recent clinical trial sponsored by Apnimed.
OHS is a condition defined by a combination of sleep-disordered breathing, obesity, and daytime hypercapnia (high levels of arterial carbon dioxide). Apnimed notes in a release that this condition is an area of unmet clinical need.
Apnimed ERS 2024 Presentation Details:
- POSTER: PA875
- Session: 82 – Early detection of obesity hypoventilation syndrome: prevalence and physiological differences within a cohort of obese patients
- Time: Sunday, Sept 8, 8 to 9:30 am CEST
- Location: RX Wien GmbH, PS-8 in poster area
- Presenter: Elisa Perger, MD, Istituto Auxologico Italiano IRCCS, Milan, School of Medicine and Surgery, University of Milano Bicocca
ID 47132947 © Monkey Business Images | Dreamstime.com
Leave a Reply